HURA

TuHURA BIOSCIENCES, INC./NV

HURA · CIK 1498382 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$0M
20172024
Net Income−$22M
20172024
Operating CF−$15M
20172024
Free Cash Flow−$15M
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.0B———————
Cost of Revenue————————
Gross Profit————————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B$-0.0B$0.0B
SG&A Expense————————
Operating Income————————
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$0.0B$0.0B$0.0B
EPS (Basic)$-1.21$-9.27$-0.52$-1.60$0.87$3.16$0.54$0.74
EPS (Diluted)$-1.21———————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B—$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B—
Investing Cash Flow$-0.0B$-0.0B$0.0B$0.0B—$-0.0B$-0.0B—
Capital Expenditures$0.0B———————
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B—
← Companies